COVID-19: Novartis to begin HCQ trials
Posted by
www.biotecnika.org
Even as there is still question hanging over the efficacy of
hydroxychloroquine (HCQ) as medication for Covid-19, Swiss drug maker
Novartis announced trials to evaluate use of HCQ for the treatment of
hospitalised patients.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-novartis-to-begin-hcq-trials/articleshow/75281460.cms
Subscribe to:
Post Comments (Atom)
Post a Comment